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Host-pathogen interactions are generally initiated by host recognition of microbial components or danger signals triggered by microbial
invasion. This recognition involves germline-encoded microbial sensors or pattern-recognition receptors (PRRs). By studying the way in
which natural selection has driven the evolution of these microbial sensors in humans, we can identify genes playing an essential role
and distinguish them from other, more redundant genes. We characterized the sequence diversity of the NOD-like receptor family,
including the NALP and NOD/IPAF subfamilies, in various populations worldwide and compared this diversity with that of other
PRR families, such as Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs). We found that most NALPs had evolved under strong
selective constraints, suggesting that their functions are essential and possibly much broader than previously thought. Conversely,
most NOD/IPAF subfamily members were subject to more relaxed selective constraints, suggesting greater redundancy. Furthermore,
some NALP genes, includingNLRP1,NLRP14, and CIITA,were found to have evolved adaptively. We identified those variants conferring
a selective advantage on some human populations as the most likely targets of positive selection. More generally, the strength of selec-
tion differed considerably between themajor families ofmicrobial sensors. Endosomal TLRs andmost NALPs were found to evolve under
stronger purifying selection than most NOD/IPAF subfamily members and cell-surface TLRs and RLRs, suggesting some degree of redun-
dancy in the signaling pathways triggered by these molecules. This study provides novel perspectives and experimentally testable
hypotheses concerning the relative biological relevance of the various families of microbial sensors in humans.Introduction
The innate immune system is responsible for the imme-
diate response of the host to infectious or noxious
assaults.1 It is based on germline-encoded microbial
sensors, known as pattern-recognition receptors (PRRs),2
which recognize conserved pathogen-associated molecular
patterns (PAMPs) from microorganisms or damage-associ-
ated molecular patterns (DAMPs) resulting from tissue
damage or cellular stress.3 The effective sensing of
PAMPs and DAMPs induces the activation of signaling
pathways that culminate in the induction of inflammatory
responses, which facilitate the eradication of pathogens
and infected, injured, or dying cells.2,3 Several PRR fami-
lies, including the Toll-like receptors (TLRs), the C-type lec-
tin receptors (CLRs), the RIG-I-like receptors (RLRs), and
the NOD-like receptors (NLRs), have been identified. The
members of these families can be distinguished on the
basis of ligand specificity, shared protein domains, cellular
distribution, and downstream signaling pathways.2,4–7 The
use of different families of PRRs provides the host with
a certain degree of functional redundancy and multiple
mechanisms for responding to a diverse range of patho-
gens.2
PRRs can be membrane bound, cytoplasmic, or secreted.
The membrane-bound TLRs—the most studied group of
PRRs—and CLRs survey the extracellular milieu and endo-
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Theered RLRs and NLRs scan the cytosol for signs of infection
or danger.2–7 The importance of the role of NLRs, in partic-
ular, has been increasingly recognized in the last few
years.6,7 In humans, the NLR proteins are encoded by
a family of 22 genes and are characterized by three distinct
domains: the ligand-sensing leucine-rich repeats (LRRs);
the NACHT domain, which mediates oligomerization,
and an effector domain, which can be a pyrin domain
(PYD), a CARD (caspase recruitment domain), or a BIR
(baculovirus IAP repeat) domain. Different NLRs have
different N-terminal domains, and this domain defines
different subfamilies, including the large NALP subfamily,
the NODs, and other proteins, such as CIITA, NLRC4 (also
known as IPAF), and NAIP.8 Substantial advances in the
functional characterization of some NLRs, such as NOD1,
NOD2, and the two NALP members NLRP1 and NLRP3
in particular, have highlighted the roles of these proteins
in the sensing of microbial and nonmicrobial danger
signals. Upon ligand recognition, these sensors either
activate NF-kB or MAP kinases to induce inflammatory
responses or activate large cytoplasmic complexes called
inflammasomes, which link the sensing of microbial
or danger signals to both the proteolytic activation of
proinflammatory cytokines and the initiation of cell
death.6,7,9,10 Increasing evidence also suggests that NLRs
have a diverse range of biological functions, extending
well beyond pathogen detection.6 These include roles in
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and tissue homeostasis (see Kufer and Sansonetti6 and
references therein). However, the precise functions,
ligands, and sensing mechanisms of most NLRs remain
to be elucidated.
Although considerable progress has been made in our
understanding of the biology of the human NLRs, as well
as of the other families of human PRRs, their relative
contributions to host survival remain largely unknown.
To address this, we used a population-genetics approach
to define the way in which natural selection has driven
the evolution of these microbial sensors. We thus
characterized the levels of genetic diversity of the NLR
members in various human populations and compared
our findings with those for other PRR families, including
cell-surface TLRs, endosomal TLRs, and cytosolic RLRs.
This approach has proved indispensable and comple-
mentary to immunological, clinical, and epidemiological
genetics studies because it has made it possible to distin-
guish between essential and more redundant functions
of host genes.11–13 In this context, we have recently
provided a proof of concept of the power of evolutionary
genetics in the context of infection by using the paradigm
of human interferons (IFNs).14 Here, we provide the first
comprehensive view of the evolutionary landscape charac-
terizing the major families of microbial sensors in humans.
We demonstrate that the strength of selection differs
considerably among the various families of human PRRs
and highlight major differences in the biological relevance
of the mechanisms triggered by these molecules in the
natural setting.Material and Methods
DNA Samples
Genetic variation at the NLRs was assessed in a total of 370
chromosomes from the HGDP–CEPH panel.15 This subpanel
includes 62 sub-Saharan Africans, 62 Europeans, and 61 East
Asians. Sub-Saharan African populations were composed of 19
Bantu from Kenya, 21 Mandenka from Senegal, and 22 Yoruba
from Nigeria; European populations included 20 French, 14
Italians, 6 Orcadians, and 22 Russians; and East-Asian populations
were composed of 10 Japanese, 4 Cambodians, 15 Han Chinese,
and 32 individuals from Chinese minorities (for further details
on the ethnic groups studied, see Table S1 in the Supplemental
Data available online). This study was approved by the Institut
Pasteur Ethics Committee (n RBM 2008.06).DNA Resequencing
We resequenced all the exonic regions of the 21 NLRs (except
from the last exon of NLRP8, i.e. 3% of the coding region, which
could not be amplified) and at least an equivalent amount of
nonexonic portions, including intronic, 50, and 30 regions. Note
that the exonic portions we resequenced generally correspond to
the longest isoform (considered for all analyses). We inspected
sequence files with the GENALYS software.16 To avoid SNP
discovery errors, we analyzed sequences by using two different
operators, and we reamplified and resequenced ambiguous poly-
morphisms. To determine ancestral states at each SNP by parsi-28 The American Journal of Human Genetics 91, 27–37, July 13, 2012mony, we used the UCSC database to retrieve the orthologous
sequences of chimpanzee, gorilla, orangutan, rhesus, baboon,
marmoset, tarsier, mouse-lemur, and bushbaby.Data Analysis
Interspecies Neutrality Tests
To estimate the direction and strength of selection within the
human species as a whole, wemeasured dS and dN—the proportion
of silent and nonsynonymous fixed differences between humans
and chimpanzees—together with pS and pN,—the proportion of
silent and nonsynonymous polymorphic sites observed within
humans—by using DnaSP package v. 5.1.17 Then, we used the
McDonald-Kreitman Poisson random field (MKPRF) method18,19
to estimate u (u ¼ qN/qS a ((dN þ pN)/(dS þ pS)), where qN and qS
are estimates of the rate of nonsynonymous and silent mutations)
and g (with g a log (dN/pN). Under neutrality, u is not signifi-
cantly different from 1. Values of u below 1 indicate a deficit of
nonsynonymous variants (both in terms of polymorphism within
humans and divergence with chimpanzees), which is consistent
with selection against amino-acid-altering variation (purifying
selection). Values of u greater than 1 reflect an excess of amino
acid changes, which is consistent with selection favoring amino
acid mutations (positive selection). Concerning g, the parameter
is negative if a gene displays an excess of amino acid polymor-
phism within humans with respect to amino acid divergence
between species (weak negative and/or balancing selection). In
contrast with purifying selection, weak negative selection does
tolerate the occurrence of nonsynonymous mutations provided
that they do not increase in frequency within the population
(i.e., they are nonlethal but slightly deleterious mutations).20,21
Conversely, positive g values reflect an excess of amino acid diver-
gence with respect to amino acid polymorphism (positive selec-
tion). The MKPRF test was performed on the sequenced NLRs,
and their results were compared with those from the RLRs and
TLRs.22,23 To assess the contributions of divergence and polymor-
phism to the patterns of purifying selection observed at some
genes, we compared the pN/pS and dN/dS ratios of the PRRs with
significant u < 1 to a genome-wide distribution of 1,596 genes ex-
hibiting u < 1.18 Using simulations conditioned on the sample
sizes and gene lengths of PRRs, we showed that the MKPRF test
has the power to detect purifying selection at a gene even when
this evolved neutrally at the divergence level; i.e., u can be signif-
icantly lower than 1 when dN/dS ¼ 1 and pN/pS < 0.6 (Figure S1).
Functional Diversity within Protein Domains
We assessed the pN/pS ratios by using the DnaSP package v. 5.1
17
and compared them within CARD, PYD, NBD, and LRR domains
in all NLRs. Because NALPs (except NLRP10) and NOD/IPAF share
an LRR domain in the C-terminal and a central NACHT domain,
we compared the pN/pS ratio within these domains in all NLRs.
Because NLRs differ in their N termini, we compared the pN/pS
ratio within the PYD domain between NALPs only and within
the CARD domain between NLRP1, NOD1, NOD2, and NLRC4.
The domain division was retrieved from the Uniprot database.24
Note that the LRR domains include the whole region carrying
the known LRRmotifs (including inter-LRR short regions) because
of the constantly evolving data concerning the bounds of these
motifs.
Diversity Indices and Intraspecies Tests
We performed haplotype reconstruction by using the Bayesian
method implemented in Phase (v.2.1.1).25 The algorithm was
run five times, and consistent results were obtained across runs.
The most likely run was retained for subsequent analyses. We used
Haploview software26 to obtain and visualize levels of linkage
disequilibrium (LD). For each population, the different summary
statistics and the sequence-based neutrality tests were performed
with DnaSP package v. 5.1.17 To detect more recent signatures of
positive selection, we used various haplotype-based tests and
levels of population differentiation. Specifically, we used the
derived intra-allelic nucleotide diversity (DIND) test based on
the ratio ipA/ipD, where ipA and ipD are the levels of nucleotide
diversity associated with the haplotypes carrying the ancestral
and derived allele for a given SNP, respectively.23 The rationale
of this test is that a derived allele that is under positive selection
and that is at high population frequencies should present lower
levels of nucleotide diversity at linked sites than would be
expected. We also used tests based on the levels of haplotype
homozygosity; such tests included the cross-population extended
haplotype homozygosity (XP-EHH) test27 obtained from the
HGDP-selection browser and, when available, the integrated
haplotype scores (iHS)28 obtained from the HapMap phase II data-
set.29 To determine the levels of population differentiation, we
assessed the FST statistics derived from the analysis of variance
(ANOVA)30 for each SNP and for each pair of populations.
Correction for the Mimicking Effects of Demography
To consider the impact of demography on the patterns of diversity,
we used simulation-based or empirical procedures. For the allele-
frequency-spectrum and DIND tests, we incorporated into our
neutral expectations two demographic models based on multiple,
noncoding genomic regions sequenced in a set of populations
similar to those used here.31,32 p values for the various neutrality
tests were estimated from 104 coalescent simulations, performed
with SIMCOAL 2.0,33 under a finite-site neutral model and consid-
ering the recombination rate of the concerned region as reported
in UCSC.34 Each of the 104 coalescent simulations was conditional
on the sample size and the number of segregating sites observed in
each gene. For the population differentiation tests, we compared
the observed FST values at each SNP at NLRs against a background
FST distribution of 640,000 SNPs genotyped in the same panel of
individuals we sequenced in this study.35 Because the genome-
wide FST distribution of the HGDP-CEPH dataset includes loci tar-
geted by positive selection,36 the comparison of NLR FST against
the HGDP-CEPH distribution represents a conservative approach
to detect selection. Because FST values depend on allele frequen-
cies, FST comparisons were conditioned to SNPs presenting similar
expected heterozygosity.Results
Genetic Diversity of the NLR Family Members in
Human Populations
We resequenced the 21 NLR genes in a panel of 185
healthy individuals of African, European, and East Asian
descent (Table S1) by using Sanger resequencing. This
sequencing method was the most appropriate choice
because, in contrast with whole-genome sequence datasets
where most NLR genes have been sequenced at low
coverage (e.g., 1000 Genomes), it allows the reliable detec-
tion of low-frequency variants, which are essential for
accurately detecting and estimating the intensity of selec-
tion. The NLRs can be broadly divided into two large
subfamilies.8 The first, the NALP subfamily, is comprisedTheof the 14 PYD-containing NALPs, which are encoded
by NLRP1–14. The second, which is here collectively
referred to as to the NOD/IPAF subfamily, includes the
five NODs—NOD1 (CARD4), NOD2 (CARD15), NLRC3
(NOD3), NLRC5 (NOD4), and NLRX1 (NOD9)—together
with CIITA (NLRA) andNLRC4 (also known as IPAF), which
have the N-terminal CARD domain common to most
NODs. The NLR NAIP was not resequenced here because
of its highly repeated genomic organization.37 For each
individual, we generated 171.2 kb of resequenced data,
67.9 kb of which corresponded to coding regions and
the rest of which corresponded to the 50and 30 UTRs and
introns.
We identified 2,084 SNPs, including 396 nonsynony-
mous SNPs, four nonsense variants, and 12 coding-region
indels (Figure 1 and Table S2). We first investigated the
genetic diversity of the NLRs by estimating levels of nucle-
otide diversity (p) over the entire sequenced region for
each gene. We then compared the p values obtained for
each gene with those expected under neutrality, which
correspond to the mean diversity levels observed for 20
autosomal noncoding regions resequenced in a panel of
populations of African, European, and Asian ancestry.31
We observed remarkable differences in the levels of nucle-
otide diversity between genes and between populations
(Figure S2). NALPs generally displayed higher or similar
levels of p than noncoding regions (0.1-0.4 SE in Africa
and Asia), whereas most NOD/IPAF members had levels
of nucleotide diversity lower than neutral expectations
(0.4–0.6 SE in all populations). We next determined the
significance of these empirical observations and formal-
ized the extent to which selection has acted upon these
gene families. To do this, we used tests that distinguish
the putative functional impact of different types of muta-
tions (e.g., nonsynonymous versus silent). More generally,
we compared the effects of natural selection on the NLRs
and other major families of microbial sensors between
human and chimpanzee lineages and within different
human populations. This should be helpful in attempts
to predict their relative biological relevance.
The NALP and NOD/IPAF Subfamilies Have Evolved
under Different Functional Constraints
To investigate whether and how natural selection has
driven the observed heterogeneous patterns of diversity,
we first estimated the direction and strength of selection
within the human species as a whole. We used the McDo-
nald-Kreitman Poisson random-field (MKPRF) test,18,19
which compares polymorphism within humans with the
divergence between humans and chimpanzees at non-
synonymous and silent sites. Specifically, this method
provides two measures of the selective pressure: u, which
compares nonsynonymous and silent mutation rates
calculated from both divergent and polymorphic sites,
and g, which relies on the ratio of divergence and polymor-
phism at nonsynonymous sites. Under neutrality, u is not
significantly different from 1. Values < 1 indicate a deficitAmerican Journal of Human Genetics 91, 27–37, July 13, 2012 29
Figure 1. Distribution of the Nonsynonymous and Nonsense Variants Identified across the NLRs in This Study
The location of each nonsynonymous and nonsense variant within the different protein domains is shown. AD stands for activation
domain. Concerning NLRX1, the N-terminal domain is neither a PYRIN nor a CARD.of nonsynonymous variants (consistent with the action of
strong negative selection, i.e., purifying selection), whereas
values >1 reflect selection favoring nonsynonymous vari-
ants (positive selection). With respect to g, negative values
indicate an excess of nonsynonymous polymorphism
within humans with respect to divergence (weak negative
selection and/or balancing selection), whereas positive
values reflect an excess of nonysnonymous divergence
with respect to that observed for silent sites (positive
selection).
Ten of the 14 NALPs (NLRP3, 4, 5, 7, 8, 9, 10, 11, 12,
and 13) and NLRC5 had a u value significantly lower
than 1, indicating a deficit of nonsynonymous variants
(Figure 2) and reflecting the action of purifying selection.
Conversely, most NOD/IPAF subfamily members (NOD1,
NLRC3, NLRC4, NLRX1, and CIITA), andNLRP2 had signif-
icantly negative g values, attesting to an excess of nonsy-
nonymous SNPs segregating in the human population
with respect to divergence (Figure S3). Inspection of the
allele frequency spectra showed that the excess of nonsy-
nonymous polymorphism observed at these genes display-
ing significantly negative g values could be accounted for
mostly by low-frequency variants (Figure S4). This suggests
that the observed excess of nonsynonymous variants is
most likely explained by a regime of weak negative selec-
tion, which has tolerated the accumulation of amino
acid changes but has prevented them from increasing to30 The American Journal of Human Genetics 91, 27–37, July 13, 2012high frequency in the population. Calculation of the ratio
of nonsynonymous to silent nucleotide diversities (pN/pS)
per domain for each gene showed that the differences in
selective constraints between the NALP and NOD/IPAF
subfamilies could not be attributed to a particular protein
domain. These results indicate that NLRs have evolved
into two distinct evolutionary groups; most NALPs have
been targeted by strong purifying selection, whereas a
weaker regime of negative selection has driven the evolu-
tion of most NOD/IPAF members.
Some NLRs Have Been Subject to Positive Selection in
Specific Populations
With a view to identifying functional variation that might
have conferred a selective advantage on the host, we
then investigated whether some NLRs had evolved adap-
tively. We thus performed various intra-species neutrality
tests on various aspects of the data, including the allele
frequency spectrum (i.e., Tajima’s D, Fu and Li’s D* and
F*, and Fay andWu’s H tests), levels of population differen-
tiation (i.e., FST), and haplotype-based tests (i.e., DIND and
iHS tests) (for extensive reviews on these statistical tests,
see Nielsen20 and Nielsen et al.21). At a first glance, tests
of the allele frequency spectrum showed that most NOD/
IPAF members were characterized by an excess of single-
tons, as the significantly negative values obtained for
the sequence-based neutrality tests attest (Table 1). These
Figure 2. Estimation of Purifying Selec-
tion Acting on Individual NLR Genes and
Genes from Other Major Families of
Microbial Sensors
We assessed the strength of purifying
selection by calculating u via the MKPRF
test. Scale bars indicate 95% confidence
intervals, and red diamonds indicate genes
with u estimates significantly lower than
1. The results for the population selection
parameter g are presented in Figure S3.
Note that nonsense mutations and coding
indels were either absent or present at very
low frequency (<1%) in NLRs (Table S2)
and, more generally, in all considered
families of PRRs other than the cell-surface
molecules TLR10 and TLR5, for which 5%
and up to 23%, respectively, of individuals
from the general population carried a
nonsense mutation.22,23patterns could be explained by local positive selection;
when a mutation (or a haplotype) is selected and increases
in frequency, the nonselected mutations become rare and
increase the number of singletons overall. However,
because no significant signals of positive selection were de-
tected on the basis of independent tests, the most parsimo-
nious explanation is that weak negative selection has
maintained polymorphisms at low frequency, leading to
the excess of observed singletons. In light of this, NOD/
IPAF members seem to have mainly evolved under the
action of weak negative selection, as also attested by the
g estimates (see MKPRF results in Figure S3). More gener-
ally, with respect to positive selection, we defined genes
under selection conservatively as those for which signifi-
cant deviations from neutrality were obtained at least
in two independent tests for selection based on different
aspects of the data (e.g., allele-frequency-spectrum tests
and FST) in a given population. Statistical significance of
the tests was assessed with either coalescent simulations
adjusted on human demography or empirical genome-
wide distributions (see Material and Methods for details).
With these conservative criteria, most NLRs showed no
significant deviation from neutral expectations, although
NLRP1,NLRP14, and CIITA represented notable exceptions
(Table 1, Figure 3, and Figure S5).
The strongest signatures of positive selection were
detected for NLRP1 (NALP1). Tests based on the allele
frequency spectrum (particularly Fay & Wu’s H and DH
tests) showed an excess of high-frequency derived alleles
in Africa and Europe (Table 1). We identified a group of
15 SNPs for which derived alleles with a frequency
>90% were found in Africa and Europe. In Europe, these
high-frequency derived alleles were in strong linkage
disequilibrium (LD) with 29 high-frequency ancestral
alleles in a haplotype block of ~45 kb (Figure S6 and Table
S3). The LD block was shorter in Africa, but most of the
SNPs characterizing the European haplotype were present
at similar frequencies. In Asia, most of the corresponding
derived alleles were fixed (Table S3), accounting for theThelack of significance of Fay and Wu’s H values (i.e., this
test is known to lose power when the targeted allele has
reached fixation). These observations suggest the occur-
rence of an event of positive selection worldwide (i.e., a
selective sweep) that is still underway in Africa and
Europe but has been completed in Asia. In haplotype-
based tests, 11 of the mutations characterizing the Euro-
pean haplotype gave iHS values >2 in Europeans from
HapMap, and one mutation gave an iHS value >2 in Afri-
cans from HapMap (Table S3).29 These significant iHS
values were observed at highly frequent ancestral alleles
only because derived alleles characterizing the selected
haplotype were not available from HapMap.29 Overall,
our results are thus consistent with a worldwide event
of positive selection targeting a long haplotype that
includes seven nonsynonymous SNPs: SNP 23999C>G
Thr246Ser, SNP 25607C>G Thr782Ser, SNP 42035C>T
Thr878Met, SNP 49993T>C Ile995Thr, SNP 53312G>A
Val1119Met, SNP 62372C>G Leu1241Val, and SNP
68479C>T Arg1366Cys (see Table S3).
At NLRP1, we detected another positive-selection
event restricted to Europe. The DIND test identified the
nonsynonymous SNP 51015G>A (Val1059Met) and four
linked intronic variants (Figure 4A), which were not in
LD (r2 ¼ 0.04) with the long haplotype described above
(Figure S6). Two of these SNPs (including the Val1059Met
variant) had iHS values<2 (Table S2), providing evidence
of the action of positive selection on the derived alleles.
Furthermore, the frequencies of the derived alleles were
higher in Europe than elsewhere (33% in Europe versus
4%–8% elsewhere; Figure S7). FST analyses identified
another nonsynonymous variant, SNP 1911T>A (Leu155-
His), as being strongly differentiated in Europe (FST ¼ 0.40
and 0.35 for Africa/Europe and Europe/Asia, respectively)
(Figure 3). Leu155His was found to be in intermediate LD
(r2 ¼ 0.52) with the Val1059Met variant and the four in-
tronic variants (Figure S6). In light of these results, and
given that DIND and iHS tests are known to be especially
adapted to detect recent positive selection, our data areAmerican Journal of Human Genetics 91, 27–37, July 13, 2012 31
Table 1. Neutrality Tests across NLR Genomic Regions
Gene
Africa Europe Asia
TD D* F* Hn DH TD D* F* Hn DH TD D* F* Hn DH
NLRP1 1.24 0.08 0.6 2.193** * 0.608 0.907 0.933 2.98*/þ NS 0.324 1.361 1.119 0.74 NS
NLRP2 0.52 0.59 0.67 0.75 NS 0.001 0.836 0.577 0.36 NS 0.013 1.334 0.941 0.57 NS
NLRP3 0.53 1.81 1.55 0.885 NS 0.462 1.191 1.08 0.056 NS 0.123 0.478 0.296 0.259 NS
NLRP4 0.6 2.36 1.94 0.538 NS 0.261 1.282 0.78 0.233 NS 0.884 0.688 0.061 0.03 NS
NLRP5 0.71 0.92 0.99 0.3 NS 0.603 0.602 0.723 0.29 NS 0.151 0.359 0.172 0.74 NS
NLRP6 0.75 1.66 1.53 0.12 NS 0.525 2.769*/þ 2.236*/þ 0.07 NS 0.258 1.689 1.124 1.33 NS
NLRP7 0.216 0.55 0.27 0.987* NS 1.388 0.457 0.347 1.56 NS 0.476 1.516 0.848 1.06 NS
NLRP8 0.5 0.43 0.55 0.078 NS 0.757 1.168 0.469 0.224 NS 0.662 0.917 0.339 0.196 NS
NLRP9 1.45 1.45 1.74 0.61 NS 0.942 2.131þ 1.997þ 0.513 NS 0.957 1.211 1.333 0.621 NS
NLRP10 1.772* 1.29 1.78 0.532 NS 0.42 0.823 0.81 0.661 NS 0.03 0.617 0.494 0.872 NS
NLRP11 0.5 0.93 0.9 0.498 NS 0.716 0.783 0.907 0.28 NS 0.205 1.137 0.709 0.275 NS
NLRP12 0.87 1.73 1.63 1.739** NS 0.489 0.432 0.065 2.072* NS 0.671 1.604 0.82 1.994* NS
NLRP13 0.69 1.28 1.23 0.15 NS 0.914 0.148 0.344 0.59 NS 1.261 0.88 1.242 0.87 NS
NLRP14 0.87 1.12 1.22 0.47 NS 0.047 0.018 0.035 0.19 NS 1.134 2.256þ 2.18*/þ 0.59 NS
NOD1 0.081 0.98 0.64 0.2 NS 0.127 0.715 0.444 1.39 NS 0.066 3.024*/þ 2.107*/þ 1.44 NS
NOD2 1.41 3.6 3.22 0.209 NS 0.344 3.278*/þ 2.509*/þ 0.032 NS 1.614*/þ 4.516**/þþ 4.063**/þþ 1.28 *
NLRC3 1.47 1.1 1.52 1.097* ** 1.692*/þ 2.151 2.35*/þ 2.344* ** 1.704*/þ 1.737 2.069þ 1.58 **
NLRC4 1.64 2.13 2.32 0.383 NS 0.73 3.746**/þ 3.166**/þ 0.199 NS 1.112 3.239*/þ 2.924*/þ 0.032 NS
NLRC5 0.76 1.98 1.72 0.05 NS 0.155 0.357 0.322 0.52 NS 0.189 2.374*/þ 1.697*/þ 0.81 NS
NLRX1 1.63 1.69 2 1.225* ** 0.925 4.097**/þ 3.447**/þ 0.273 NS 1.295 3.1*/þ 2.889*/þ 0.021 NS
CIITA 0.84 1.76 1.63 0.072 NS 0.194 0.412 0.187 0.22 NS 0.385 2.136þ 1.284 0.129 NS
Abbreviations are as follows: TD, Tajima’s D; D*, Fu & Li’sD*; F*, Fu & Li’s F*; Hn, normalized Fay &Wu’s H; DH, Tajima’s D and Fay &Wu’s H p values combined. A
double asterisk indicates a p value % 0.01, and a single asterisk indicates a p value % 0.05, both according to the model of Voight et al.32 A double plus sign
indicates a p value % 0.01, and a single plus sign indicates a p value % 0.05, both according to the model of Laval et al.31 Most of the members of the
NOD/IPAF subfamily gave strongly negative values of Fu & Li’s D* and F*, indicative of an excess of singletons; this excess was significant in Europe and Asia
in most cases. However, most gave no other significant signature of positive selection, suggesting that these patterns are the consequence of weak negative
selection, as the results obtained for the population selection parameter g in the MKPRF test attest (Figure S3).consistent with an independent, more recent event of
positive selection targeting NLRP1 in Europe.
Another positive-selection signal was identified for
NLRP14 (also known as NALP14). This gene displayed an
excess of low-frequency alleles in Asia, and the DIND
test identified the nonsynonymous SNP 19221G>A
(Glu808Lys) variant as an outlier in the three populations,
particularly in Asia (Table 1, Figure 4B, and Figure S5).
Haplotype-based tests confirmed this signature, and XP-
EHH values greater than 2 were recorded for Asia.27 Inter-
estingly, inmost HGDP-CEPHAsian populations, the high-
est XP-EHH value in this genomic region was observed for
the Glu808Lys variant and two intronic SNPs.35 Together,
these observations suggest that Glu808Lys is the most
likely target of either stronger or earlier selection in Asian
populations, consistent with the clear star-like shape of
the NLRP14 network, particularly in Asia (Figure S8).
Finally, we detected a signature of positive selection for
the NOD/IPAF member CIITA on the basis of the FST32 The American Journal of Human Genetics 91, 27–37, July 13, 2012analysis, which identified SNP 286 (rs3087456) as highly
differentiated in Europe and SNPs 730 (rs4781010)
and 561 (rs2071170) as highly differentiated in Asia
(Figure 3). The signal in Europe was confirmed by the >2
iHS value obtained for SNP –712 (rs12596540) and
other HapMap SNPs (rs8052975, rs6498114, rs12922863,
rs6498116, rs12928665, and rs11074934) in high LD (r2
> 0.6) with SNP 286. These results support the occur-
rence in Europe of a positive-selection event targeting
the CIITA promoter region.
Lastly, the cases of NLRP6, NLRP12, and NOD2 are
worthy of note, despite the fact that the signatures of
selection observed at these genes were supported by a
single neutrality test and should thus be interpreted
cautiously. For NLRP6, neutrality tests revealed an excess
of low-frequency alleles in Europe (Table 1), but no other
signal of selection was detected. In turn, in Asia we identi-
fied the nonsynonymous SNP 1652C>A (Leu163Met)
as being strongly differentiated (FST ¼ 0.58 and 0.51
Figure 3. Levels of Population Differentiation at the NLRs
The FST statistic is presented as a function of heterozygosity for each SNP in (A) Africans versus Europeans, (B) Africans versus East-Asians,
and (C) Europeans versus East-Asians. The 95th and 99th percentiles of the Human Genome Diversity Panel-Centre d’Etude du Polymor-
phismeHumain (HGDP-CEPH) genotyping dataset for the same individuals as those studied here are shown as dashed lines, whereas the
blue area corresponds to the 99.9th percentile. Black and red points represent silent and nonsynonymous SNPs, respectively. For each
outlier SNP, the gene name, followed by its position respective to the ATG, is indicated. Outlier SNPs separated by a comma correspond
to SNPs in complete LD, and nonsynonymous SNPs are underlined. Note that, in Asian populations, a group of SNPs inNLRP6, including
the nonsynonymous SNP 1652C>A (Leu163Met), displayed some of the highest levels of differentiation of any of the SNPs studied.for Africa/Asia and Europe/Asia, respectively) (Figure 3).
With respect to NLRP12, we detected an excess of high-
frequency derived alleles in all populations, which is
consistent with a worldwide selective sweep (Table 1). For
NOD2, given the strongly negative values of the tests,
particularly in Asia, the highly significant excess of rare
alleles in Europe and Asia suggests the action of positive
selection (Table 1).
Global Patterns of Selection Differ between the Major
Families of Microbial Sensors
Finally, we evaluated the patterns of selection for the NALP
and NOD/IPAF subfamilies in the context of the results we
obtained for other major families of microbial sensors.22,23
These families included the TLRs—both those located
in the endosome (TLR3, TLR7, TLR8, and TLR9) and those
expressed on the cell surface (TLR1, TLR2, TLR4, TLR5,
TLR6 and TLR10) —and the cytosolic RLRs—DDX58
(RIG-I), IFIH1 (MDA5), and DHX58 (LGP2). The MKPRF
test was performed on the 34 genes encoding these recep-
tors. On the basis of these test results, we identified a
group of genes subject to strong selective constraints—
this group included most NALPs and the endosomal
TLRs—and a group of genes subject to weaker evolutionary
constraints—this group included most NOD/IPAF sub-
family members, the cell-surface TLRs, and the cytosolic
RLRs (Figure 2). We next evaluated the respective contribu-
tions of divergence and polymorphism to the patterns of
purifying selection observed in the group of NALPs and
endosomal TLRs, which present u values significantly
lower than 1. To do so, we compared their pN/pS and
dN/dS values with the genome-wide distribution of pN/pS
and dN/dS for genes presenting the same features (i.e., for
1,596 genes with significant u < 1; see Figure S1).18
None of our PRR genes presented pN/pS or dN/dS valuesThethat were significantly higher than expected, suggesting
that the evolutionary constraints observed for this group
of PRRs result from the continuous action of purifying
selection since the human-chimpanzee divergence.Discussion
In this study, we have shown that the subfamilies of
NLRs have followed very different evolutionary pathways.
NALPs, the least-studied group of NLRs, have mostly
evolved under strong purifying selection and are character-
ized by an overall deficit of functional diversity. Indeed,
this gene subfamily shows a significant enrichment in
genes under the action of strong purifying selection
(p ¼ 1 3 104, 71% observed versus 20% expected at the
genome-wide level on the basis of ~11,600 genes, see
Bustamante et al.18). By contrast, most members of the
NOD/IPAF subfamily have been subject to more relaxed
selection constraints, reflecting a higher degree of redun-
dancy. These observations are consistent with the idea
that most NALPs acquired a function that is essential and
nonredundant in host survival, as well as with the rapid
elimination of mutations of these genes from the popula-
tion as a result of their highly deleterious effects. Our
observations are supported by medical genetic studies
involving NLRP3 (NALP3; which is subject to the highest
degree of evolutionary constraint) in which missense
mutations have been associated with rare severe inflam-
matory diseases (MIM 606416).38,39 NLRP3 expression is
essentially limited to immune and nonkeratinizing epithe-
lial cells,40 and the protein encoded by this gene is known
to activate caspase-1 in the sensing of bacteria or DAMPs.6
The purifying-selection regime under which this gene
has evolved suggests an important role of this sensor inAmerican Journal of Human Genetics 91, 27–37, July 13, 2012 33
Figure 4. Detection of Recent Positive Selection Acting on
NLRP1 in Europe and on NLRP14 in Asia
We plotted ipA/ipD values against derived allele frequencies (DAFs)
for (A) NLRP1 in Europe and (B) NLRP14 in Asia. We obtained p
values by comparing the ipA/ipD values for NLRP1 and NLRP14
with the expected values obtained from 104 simulations by using
a best-fitted demographic model of human populations; this
model is the most conservative in the context of the detection
of positive selection.31 The upper dashed line on the graph corre-
sponds to the 99th percentile, and the lower line corresponds to
the 95th percentile. Black and red points represent silent and
nonsynonymous SNPs, respectively. Outlier SNPs separated by
a comma correspond to SNPs in complete LD, and nonsynony-
mous SNPs are underlined. As for NLRP1, in addition to the
selected SNP 51015G>A (Val1059Met), our analyses also identi-
fied another nonsynonymous SNP (SNP 62201G>A, Val1184Met)
linked to an intronic variant (SNP 63236G>A). This signal might
be a complex repercussion on the worldwide selective sweep. For
the DIND analyses of all genes in all populations, see Figure S5.caspase-1-mediated immunity signaling and in processes
that are independent of caspase-1 or that are unrelated to
pathogen recognition.6,41
NALPs are encoded by a multigene family, most of the
members of which are under strong selective constraints.
This situation contrasts with theoretical predictions about
multigene families, many of the members of which can
become pseudogenes or are subject to relaxed selective
constraints.42 This observation highlights the important
role that most NALPs might have, probably in a much
more diverse range of functions than the mere sensing of
microbial and danger signals.6 For example, increasing
evidence suggests that NALPs are involved in the mainte-
nance of intestinal homeostasis, as shown for the murine
Nalp3, the absence of which is associated with greater
tissue damage and colitis.43,44 It is also becoming evident
that many NALP genes are expressed specifically in
gametes and embryos,45 consistent with an important
role in early development and reproduction. Mutations
of the human NLRP7, for example, are associated with
abnormal human pregnancies, spontaneous abortions,
and intrauterine growth retardation (MIM 609661).46
These reproductive and developmental functions might
be more closely related to immune functions than previ-
ously anticipated.8 Indeed, activation of the proinflamma-
tory cytokine IL-1b after inflammasome formation is
essential for ovulation and oocyte maturation.47 However,
the genuine functions of most NALPs remain poorly docu-
mented and little studied. In this context, our evolutionary34 The American Journal of Human Genetics 91, 27–37, July 13, 2012data are particularly informative because they are consis-
tent with key roles for most NALPs in host survival, high-
lighting the need for functional data on this major family
of ATPases in humans in order for its physiological rele-
vance to health and disease to be assessed.
Our analyses have also revealed that some NALP and
NOD/IPAF members have evolved adaptively, attesting to
the presence of functional variation that might confer an
advantage to specific human populations. The patterns
depicted at NLRP1 (NALP1), which displays the strongest
signals of positive selection, are consistent with an event
of positive selection at a haplotype comprising seven non-
synonymous changes. NLRP1 is one of the few NALPs for
which a PRR function has been well documented.6,48
These seven identified amino acid changes might therefore
have conferred a selective advantage related to microbial
sensing and might underlie differences in susceptibility
to infections and immunity-related disorders. Further-
more, at NLRP1we identified an independent, more recent
positive-selection signature restricted to Europe; in this
signature, two nonsynonymous changes (Val1059Met
and Leu155His) displayed positive-selection signals. Inter-
estingly, the Leu155His variant has been shown to be
associated with various autoimmune diseases, including
Addison’s disease, type I diabetes, and vitiligo (MIM
606636).49,50 However, most of our analyses localized the
signature of selection to Val1059Met, rather than to
Leu155His, suggesting that Val1059Met is the actual target
of selection. The action of selection on Val1059Met might
have thus increased the frequency, among Europeans, of
the genetically linked Leu155Hismutation, which is nowa-
days held responsible for several autoimmune diseases.
These findings provide support for the hypothesis that
the current high incidence of autoimmune or inflamma-
tory disorders results from past adaptation to infectious
agents.11,51 Finally, the positively selected SNP 286
(rs3087456) at CIITA has been associated with different
susceptibilities to inflammatory diseases, such as rheuma-
toid arthritis, multiple sclerosis, and myocardial infarction
(MIM 600005).52 The overlap between the positive selec-
tion signatures observed for someNLRP1 andCIITAvariants
and previous associationswith disease states provides proof
of concept for the use of this evolutionary approach to
predict the functional impact of other, as-yet-uncharacter-
ized positively selected variants of NLRP1 and NLRP14
and to evaluate their potential implications in human
disease. The signatures of positive selection observed at
other NLRs, such as NLRP6, NLRP12, and NOD2, were not
confirmed by various independent tests of selection and
therefore failed to pass our stringent criteria. However, we
cannot rule out the possibility that positive selection, prob-
ably inamoremodestway,mighthave targeted these genes.
Pathogens harbor multiple ligands that are sensed by
multiple families of PRRs through crosstalk between the
corresponding signaling pathways,2 which may display
various degrees of redundancy. Our results for NLRs there-
fore cannot be interpreted in isolation. Our study revealed
Figure 5. Hierarchical Model Outlining the Evolutionary Dynamics and Biological Relevance of the Various Families of PRRs
This representation is based on the intensity of the selective constraints (based on the MKPRF results) detected for the 34 PRRs. These
analyses allowed us to distinguish three groups of genes: genes under purifying selection (u < 1, in red), genes under weaker selective
constraints (g< 0, in yellow), and genes for which no deviation from neutrality was detected (in gray). Color intensity is proportional to
the –log(p value) of u or g tests. Cellular sublocalization, protein domains, and ligands are given as an indication but are not exhaustive.important differences in the intensity of selection driving
the evolution of the major families of microbial sensors
and provided information about the biological relevance
of the mechanisms triggered by these molecules (Figure 5).
For PRRs specialized in the sensing of nucleic acids, partic-
ularly those from viruses, we found that endosomal TLRs
were under stronger evolutionary constraints than cyto-
solic RLRs, suggesting a nonredundant, essential role for
endosomal TLRs. Indeed, TLRs and RLRs use specific adap-
tors to initiate their respective signaling cascades, but these
pathways ultimately converge in the production of type-I
IFNs and proinflammatory cytokines.4,5 The more-relaxed
evolutionary constraints on RLRs than on endosomal
TLRs might therefore reflect some redundancy of this
system in antiviral immunity. For PRRs involved in the
sensing of nonnucleic acid products, mostly from bacteria,
and stress signals, we found that the members of the NALP
family were generally subject to strong purifying selection,
whereas NOD/IPAF subfamily members and cell-surface
TLRs have evolved under weaker constraints. This supports
a higher degree of redundancy of these latter two groups
of microbial sensors.
In conclusion, our analyses allowed us to distinguish
three groups of innate-immunity genes that differ in
their evolutionary patterns: genes under strong selective
constraints, genes under weaker constraints, and genes
for which no deviation fromneutrality was detected.Muta-
tions in genes evolving under the effects of strong purifyingTheselection are likely to be associated with severe clinical
phenotypes and, therefore, strongly constrained genes are
candidates for involvement in individual, rare Mendelian
deficiencies. Conversely, mutations in genes evolving
under more relaxed constraints (i.e., weak negative selec-
tion or neutrality) will generally have a more modest
impact on host survival, although they might subtly
modulate complex susceptibility to disease at the popula-
tion level, as illustrated by the case of NOD2 variation
and susceptibility to Crohn disease.53–55 These data open
new research perspectives and facilitate the formulation
of experimentally testable hypotheses by providing a
general hierarchical model for the biological relevance of
the various microbial sensors, some of which are essential
and some of which are more expendable. These findings
should stimulate future functional studies aiming to
determine whether the strong constraints on the genes
for some of these sensors, including the little-studied
NALPs, provide evidence of the importance of the
PRR functions putatively mediated by these sensors or,
more generally, for broader processes extending to basic,
early developmental mechanisms and the maintenance
of body homeostasis.Supplemental Data
Supplemental data include eight figures and three tables and can
be found with this article online at http://www.cell.com/AJHG/.American Journal of Human Genetics 91, 27–37, July 13, 2012 35
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